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2.9 (218.3 to 29.7)% (P 5 0.16 between diets), respectively].Low-protein diet and kidney function in insulin-dependent dia-
Arterial blood pressure was comparable in the two groups ofbetic patients with diabetic nephropathy.
patients during phase I and II.Background. Initiation of a low-protein diet (LPD) in pa-
tients with various nephropathies induces a faster initial and Conclusions. Dietary protein restriction for four weeks in-
slower subsequent decline in the glomerular filtration rate duces a reversible decline in GFR and albuminuria in insulin-
(GFR). Whether this initial phenomenon is reversible or irre- dependent diabetic patients with diabetic nephropathy, whereas
versible remains to be elucidated. systemic blood pressure remains unchanged.
Methods. We performed an eight-week prospective, ran-
domized, controlled study comparing the effect of an LPD with
a normal-protein diet (NPD) in 29 insulin-dependent diabetic
patients with diabetic nephropathy. At baseline, the patients Diabetic nephropathy, characterized by persistent al-
were randomized to either an LPD (0.6 g · kg21 · 24 hr21, LPD buminuria, a relentless decline in glomerular filtration
group, N 5 14) or their NPD (NPD group, N 5 15) for four rate (GFR), and raised arterial blood pressure, developsweeks (phase I). Between weeks 4 and 8, all patients received
in nearly 40% of all insulin-dependent diabetic (IDDM)their NPD (phase II, recovery). Dietary protein intake (g ·
patients [1, 2]. Epidemiological studies of the naturalkg21 · 24 hr21), GFR (51Cr-EDTA, ml · min21 · 1.73 m22),
albuminuria (enzyme-linked immunoadsorbent assay, mg · 24 cause of diabetic nephropathy have reported a median
hr21), and arterial blood pressure (Hawksley random zero sphyg- survival time after onset of persistent albuminuria of only
momanometer, mm Hg) were measured at baseline and after
5 to 10 years [3–5]. Restriction of dietary protein intakefour- and eight-weeks of follow-up. During the investigation,
has been proved to slow the progression of renal diseaseall patients in the LPD group (N 5 12) and in the NPD group
(N 5 14) received their usual antihypertensive treatment. in many experimental animal models [6, 7]. Nevertheless,
Results. At baseline, the LPD group and the NPD group conflicting evidence of a beneficial effect of dietary pro-
were comparable regarding dietary protein intake, GFR, albu-
tein restriction on the progression of nondiabetic andminuria, and arterial blood pressure. During phase I, a signifi-
diabetic renal diseases has been presented in humanscant decline in dietary protein intake, GFR, and albuminuria
(mean, 95% CI) was observed in the LPD group [0.4 (0.3 to [8–13]. This discrepancy may in part be due to the phe-
0.5) g · kg21 · 24 hr21, 8.6 (3.2 to 13.9) ml · min21 · 1.73 m22, nomenon that initiation of dietary protein restriction
and 28.7 (14.0 to 40.9)%, respectively] compared with the NPD induces a faster initial and slower subsequent decline ingroup [0.0 (20.1 to 0.2) g · kg21 · 24 hr21 (P , 0.0001 between
the GFR [14]. This short-term effect may confound thediets), 2.5 (21.8 to 6.8) ml · min21 · 1.73 m22 (P 5 0.07 between
interpretation of clinical trials, especially if they are ofdiets), and 0.0 (220.1 to 23.5)% (P , 0.05 between diets),
respectively]. Conversely, during phase II, a significant increase short duration (less than two to three years) and are deal-
in dietary protein intake, GFR, and albuminuria [mean, 95% ing with slow progressive renal diseases [14]. Whether
CI; 0.3 (0.2 to 0.5) g · kg21 · 24 hr21, 5.9 (0.8 to 11.1) ml · min21 ·
this initial faster decline in GFR is caused by a functional1.73 m22, and 25.0 (4.5 to 49.6)%, respectively] took place in
(hemodynamic) effect, which will not attenuate overthe LPD group compared with the NPD group [0.0 (20.2 to
0.1) g · kg21 · 24 hr21 (P , 0.0001 between diets), 22.9 (26.4 time, or whether it reflects an irreversible phenomenon
to 0.6) ml · min21 · 1.73 m22 (P , 0.01 between diets), and (structural damage) is unknown. These mechanisms must
be revealed in order to make a valid interpretation of
the potential beneficial effect of dietary protein restric-Key words: IDDM, glomerular filtration rate, albuminuria, arterial
blood pressure, protein intake. tion on the progression of diabetic and nondiabetic ne-
phropathies.
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Table 1. Clinical data in 29 insulin-dependent diabetic patients with 15 patients were allocated to each diet group, but one
diabetic nephropathy at baseline
patient from the LPD group was unwilling to continue
LPD group NPD group the study after randomization and was excluded from
(N 5 14) (N 5 15) P the calculation. All subjects included in the study were
Females N 6 5 white, and all gave informed consent to participate in
Age years 47 (3) 44 (2) 0.45
the study. The study was approved by the local ethicsDuration of diabetes
years 29 (2) 29 (2) 0.91 committee.
Duration of diabetic nephropathy
years 9 (2) 10 (2) 0.62 Protein intake
Insulin dosage
U·kg21·24 hr21 0.56 (0.03) 0.55 (0.03) 0.70 Dietary protein intake (g · 24 hr21) was estimated on
Body mass index the basis of three consecutive 24-hour urine collections
kg·m22 25 (1) 25 (1) 0.95
completed immediately before the visit at baseline, weekBody weight kg 75.4 (3.0) 72.2 (3.9) 0.52
HbA1c % 8.4 (0.3) 8.6 (0.3) 0.55 4, and week 8 using the urinary excretion of urea nitrogen
[17]. The variation in urinary creatinine excretion wasData are mean (sem). Abbreviations are: LPD, low protein diet (recom-
mended: 0.6 g·kg21·24 hr21); NPD, normal protein diet. 4.1% (between baseline and the visit at four weeks),
2.4% (between the visit at four and eight weeks), and
1.8% (between baseline and eight weeks). Protein intake
was standardized for body weight (kg). To reduce protein
in IDDM patients with diabetic nephropathy before, dur-
intake, all food for lunch and dinner was prepared in
ing, and after short-term low-protein diet (LPD).
the hospital kitchen, was deep-frozen, and was delivered
at home to the patients in the LPD group. Advised by
the dietitian, these patients prepared their own breakfastMETHODS
and snacks. At baseline, an isocaloric LPD of 0.6 g · kgDesign and subjects
body weight21 · 24 hr21 was prescribed to patients in the
A prospective, randomized, controlled study for eight LPD group, whereas patients in the NPD group were
weeks that compared the effect of LPD and a normal- told to continue their normal diet. In order to maintain
protein diet (NPD) on GFR, albuminuria, and blood an isocaloric diet, an increase in carbohydrates (bread,
pressure was carried out in IDDM patients with diabetic fruit, and vegetables) and fats (monounsaturated fatty
nephropathy (Table 1). At baseline, the patients were acids) was recommended. Patients with albuminuria $
randomized to either LPD (LPD group) or NPD (NPD 2 g · 24 hr21 were allowed an additional 1.0 g of dietary
group) for four weeks (phase I). Between week 4 and protein per extra gram of urinary albumin. Furthermore,
week 8, all patients received NPD (phase II, recovery). energy intake (KJ) and other nutrients were assessed at
Thirty consecutive IDDM patients with diabetic ne- each visit by a three-day dietary record performed by
phropathy who fulfilled the following inclusion criteria the patients at home. Nutritional data were calculated
were enrolled in this study: diabetic nephropathy (diag- by a national nutritional data program (Danish Catering
nosed clinically according to established criteria: albu- Center).
minuria of more than 300 mg · 24 hr21 in at least two Apart from the urine collection, all of the investiga-
out of three sterile urine samples, a duration of diabetes tions were carried out with the patients in the supine
of 10 years or more, the presence of diabetic retinopathy, position between 8 a.m. and 1 p.m. The investigations
and no clinical or laboratory evidence of kidney or uri- were started in the morning after an overnight fast. Pa-
nary tract disease) [15], GFR $ 25 ml · min21 · 1.73 tients had breakfast and morning insulin approximately
m22, and age between 18 and 60 years. Reduced urinary 30 minutes after the start of the GFR investigation. They
albumin excretion rate even into the normal range can be drank 150 to 200 ml tap water per hour during the study
observed in IDDM patients with diabetic nephropathy period.
during antihypertensive treatment [16]. All patients had
Glomerular filtration ratebeen insulin-dependent from the time of diagnosis, and
all were receiving at least two daily injections of insulin. GFR was measured after a single intravenous injection
Patients were excluded if they had malignant hyperten- of 3.7 MBq 51Cr-ethylenediaminetetraacetic acid (EDTA)
sion, a previous history of congestive heart failure and at 8 a.m. by determining the radioactivity in venous blood
myocardial infarction, or coronary bypass surgery within samples taken 180, 200, 220, and 240 minutes after the
the last three months. During the investigation, patients injection [18, 19]. Extra renal loss was corrected for by
received their usual antihypertensive treatment [LPD subtracting 3.7 ml · min21 [20]. The small underestima-
group, N 5 12; angiotensin-converting enzyme (ACE) tion (10%) of 51Cr-EDTA renal clearance versus renal
inhibitors (N 5 12), NPD group, N 5 14; ACE inhibitors clearance of inulin was corrected for by multiplying the
EDTA clearance by 1.10 [20]. The results were standard-(N 5 11) and non-ACE inhibitors (N 5 3)]. Originally,
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Table 2. Baseline dietary protein intake, energy intake, glomerularized for 1.73 m2 body surface area. The mean day-to-
filtration rate, albuminuria and blood pressure in 29 insulin-
day coefficient of variation in the GFR is 4% in our dependent diabetic patients with diabetic nephropathy
laboratory.
LPD group NPD group
(N 5 14) (N 5 15) PBlood pressure
Dietary protein intake
Office blood pressure was measured on the right arm g·kg21·24 hr21 1.2 (0.1) 1.1 (0.1) 0.53
Energy intakeafter at least 30 minutes of rest in the supine position
KJ·kg21·24 hr21 124 (6) 129 (7) 0.63with a Hawksley random zero sphygmomanometer and
Glomerular filtration rate
an appropriate cuff size [25 · 12 cm (upper arm circumfer- ml·min21·1.73 m22 94 (6) 92 (6) 0.78
Albuminuriaa 397 438 0.37ence of less than 35 cm) and 30 · 15 cm (upper arm
mg·24 hr21 (14 to 4091) (94 to 2934)circumference of more than 35 cm)]. Diastolic blood
Mean arterial blood pressure
pressure was recorded at the disappearance of Korotkoff mm Hg 95 (2) 100 (3) 0.26
sounds (phase V). The individual blood pressure level Data are mean (sem).
a Median (range); LPD, low protein diet (recommended: 0.6 g·kg21·24 hr21);was determined as the mean of at least two measure-
NPD, normal protein dietments performed during the GFR determination.
Albuminuria, fractional clearance of albumin and
urinary sodium excretion
albuminuria, which was tested by the Mann–Whitney
On the basis of the three consecutive 24-hour urine U-test. Spearman’s rank correlation coefficient was used
collections completed immediately before each visit, al- to analyze data for correlations.
buminuria and urinary sodium excretion were measured All calculations were made using SPSS for Windows
by an enzyme-linked immunoadsorbent assay (coeffi- (SPSS Inc., Chicago, IL, USA). A P value of less than
cient of variation was 2.1%) [21] and a flame photometric 0.05 was considered significant (two tailed).
method, respectively. Fractional clearance of albumin
(ualb) was obtained by dividing the clearance of albumin
[calculated as (U · V)/P, where U is urine albumin con- RESULTS
centration, V is urine flow, and P is plasma albumin At baseline
concentration] with the measured GFR to correct albu-
Dietary protein intake, energy (calorie) intake, GFR,min excretion for changes in plasma albumin concentra-
albuminuria, and arterial blood pressure were compara-tion and in GFR.
ble in the LPD group and the NPD group (Table 2).
Furthermore, carbohydrate intake, fat intake, and alco-Hemoglobin A1c and blood glucose
hol intake were alike (data not shown).From venous blood samples, hemoglobin A1c (HbA1c)
was measured by high-performance liquid chromatogra- Phase I
phy (Variant; Bio-Rad Laboratories, Hercules, CA,
Nutritional data. Both dietary protein and energy in-USA). The normal range of HbA1c in our laboratory is
take significantly decreased in the LPD group during4.1% to 6.4%. The venous blood glucose concentration
phase I, whereas they remained stable in the NPD groupwas measured two to four times during the clearance
(Table 3). Carbohydrate intake, fat intake, and alcoholperiod by a One Touch II (Lifescan, Milpitas, CA, USA).
intake remained stable in both diet groups during phase I
Statistical analysis (data not shown).
GFR, albuminuria, fractional clearance of albumin,Clinical characteristics at baseline are given as mean 6
and urinary sodium excretion. Concomitantly with thesem or median (range). During follow-up urinary excre-
decrease in dietary protein intake, a significant declinetion of albumin, sodium and the fractional clearance of
in GFR, albuminuria, and fractional clearance of albu-albumin were logarithmically transformed before statis-
min was observed in the LPD group during phase I,tical analysis because of their positively skewed distribu-
whereas GFR, albuminuria, and fractional clearance oftion. A mean of nutritional data from the three-day di-
albumin remained stable in the NPD group (Table 3).etary records and a mean of the venous blood glucose
No significant changes in urinary sodium excretion wasmeasurements taken at each visit were used for statistical
seen in either diet group (Table 3).analysis. Changes in variables between visits are ex-
Blood pressure. Nonsignificant changes in mean arte-pressed as means with 95% confidence intervals. An
rial blood pressure were observed in both groups (Table 3).unpaired t-test was used to compare baseline data and
Body mass index, HbA1c , and serum albumin. Bodychanges in nutritional data, GFR, albuminuria, and
mass index (BMI) and metabolic control (HbA1c) wereblood pressure between the LPD group and the NPD
group during phases I and II, except baseline data of significantly reduced during LPD, but these changes
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Table 3. Changes in dietary protein intake, energy intake, glomerular filtratioin rate, albumniuria, fractional clearance of albumin (ualb),
mean arterial blood pressure, body mass index (BMI), hemoglobin A1c (HbA1c) and serum albumin,
in 29 IDDM patients with diabetic nephropathy, during the study
Phase I Phase II
LPD group NPD group P LPD group NPD group P
Changes in (N 5 14) (N 5 15) Inter-group (N 5 14) (N 5 15) Inter-group
Dietary protein intake
g·kg21·24 hr21 20.4 (20.5 to 20.3)a 0.0 (20.2 to 0.1) , 0.0001 0.3 (0.2 to 0.5)I,a 0.0 (20.2 to 0.1) , 0.0001
Energy intake
MJ·24 hr21 20.9 (21.7 to 20.1) 0.5 (20.6 to 1.6) , 0.05 0.1 (21.5 to 1.7) 20.3 (21.3 to 0.6) 5 0.57
Glomerular filtration rate
ml·min21·1.73 m22 28.6 (213.9 to 23.2)c 22.5 (26.8 to 1.8) 5 0.07 5.9 (0.8 to 11.1)II,b 22.9 (26.4 to 0.6) , 0.01
Albuminuria % 228.7 (240.9 to 214.0)c 0.0 (223.5 to 20.1) , 0.05 25.0 (4.5 to 49.6)III,b 2.9 (218.3 to 29.7) 5 0.16
Urinary sodium
excretion % 21.8 (216.6 to 15.7) 10.6 (213.5 to 41.2) 5 0.40 11.4 (29.4 to 37.2) 2.2 (217.4 to 26.6) 5 0.54
ualb % 222.6 (237.6 to 23.9)b 5.4 (219.4 to 37.8) 5 0.07 11.6 (28.5 to 36.2)IV 10.4 (210.2 to 35.6) 5 0.93
Mean arterial blood
pressure mm Hg 22.8 (25.8 to 0.2) 20.7 (25.3 to 3.9) 5 0.43 21.4 (24.9 to 2.0) 20.1 (26.4 to 6.1) 5 0.70
BMI kg·m22 20.5 (20.8 to 20.2)c 20.2 (20.4 to 0.1) 5 0.07 0.3 (0.1 to 0.5)V,d 0.2 (0.0 to 0.5) 5 0.55
HbA1c % 20.5 (20.7 to 20.2)d 20.2 (20.5 to 0.2) 5 0.21 0.1 (20.1 to 0.4)VI 20.1 (20.3 to 0.2) 5 0.27
Serum albumin
g/liter 20.2 (21.3 to 0.8) 0.3 (20.5 to 1.0) 5 0.41 20.6 (21.2 to 0.1) 20.7 (61.7 to 0.3) 5 0.87
Data are: mean (95% CI). Abbreviations are: LPD, low protein diet (recommended: 0.6 g·kg21·24 hr21) and NPD, normal protein diet. In Phase I, at baseline the
patients were randomized to either the LPD (LPD group) or NPD (NPD group) for 4 weeks. Phase II, between week 4 and week 8 all patients received NPD.
a P , 0.0001, b P , 0.05, c P , 0.005, d P , 0.01 during Phase I or Phase II (intra-group comparison)
I P , 0.0001, II P , 0.006, III P , 0.002, IV P , 0.05, V P , 0.001 and VI P , 0.002 compared to the changes seen during Phase I in the LPD group
were not significantly different from the changes seen in was significantly increased in the LPD group, but this
the NPD group. Nonsignificant changes in serum albu- change was not significantly different from the change
min were observed in both diet groups (Table 3). in BMI seen in the NPD group. Metabolic control (HbA1c)
was comparable in the two diet groups. Nonsignificant
Phase II changes in serum albumin were observedin both diet
groups (Table 3).Nutritional data. In the LPD group, dietary protein
intake increased significantly during the last four weeks Blood glucose and insulin dosage. The blood glucose
levels during the GFR measurements were comparableof investigation (phase II), whereas it remained constant
in the NPD group (Table 3). Energy intake (Table 3), at baseline, week 4, and week 8 in both the LPD group
(8.5 6 0.8 vs. 9.8 6 1.1 vs. 8.7 6 0.9; mean 6 sem; NS)carbohydrate intake, fat intake, and alcohol intake were
comparable in the two diet groups (data not shown). and the NPD group (10.9 6 0.9 vs. 9.5 6 0.9 vs. 8.6 6
1.1; NS). Correspondingly, the daily dose of insulinGFR, albuminuria, fractional clearance of albumin,
and urinary sodium excretion. Normalization in dietary (U·kd21·24 hr21) remained unchanged at baseline, week 4,
and week 8 in both the LPD group (42 6 3 vs. 42 6 3protein intake was accompanied by a significant increase
in GFR and albuminuria in the LPD group, whereas vs. 43 6 3; NS) and the NPD group (39 6 2 vs. 39 6 2
vs. 40 6 2; NS).GFR and albuminuria remained stable in the NPD group
(Table 3). In the LPD group, the level of GFR was Correlations. In the whole group of patients, a signifi-
cant correlation between the relative change in dietaryidentical at baseline and after eight weeks [median
(range); 94 (81 to 108) ml · min21 · 1.73 m22 and 92 (79 protein intake and relative change in albuminuria during
phase I (r 5 0.51, P , 0.01) and phase II (r 5 0.38, P 5to 105) ml · min21 · 1.73 m22, NS]. The changes in the
fractional clearance of albumin were alike in the two 0.05) was demonstrated (Fig. 1), whereas no significant
association was found between the relative change in di-diet groups during phase II. The change in fractional
clearance of albumin during phase I was significantly etary protein intake and the relative change in GFR, either
during phase I (r 5 0.25, P 5 0.22) or phase II (r 5different from the change during phase II in the LPD
group, but not the NPD group (Table 3). No significant 0.33, P 5 0.10). During phase I, a significant correlation
between the initial decline (absolute) in GFR and base-changes in urinary sodium excretion were seen in either
diet group (Table 3). line GFR (range 58 to 135 ml · min21 · 1.73 m22) was
found in the LPD group (r 5 0.53, P , 0.05). RelativeBlood pressure. Alterations in mean arterial blood
pressure were comparable in the LPD group and the changes in mean arterial blood pressure (DMABP%)
correlated significantly with relative changes in GFRNPD group (Table 3).
BMI, HbA1c , and serum albumin. Body mass index (DGFR%) in the NPD group during phase I (r 5 0.71,
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P , 0.005), but not significantly during phase II (r 5
0.40, P 5 0.14; Fig. 2). Contrarily, no association between
DMABP% and DGFR% was found in the LPD group
either during phase I (r 5 20.06, P 5 0.84) or phase II
(r 5 0.09, P 5 0.77). No significant correlations between
relative changes in albuminuria and relative changes in
mean arterial blood pressure or relative changes in GFR
were found.
DISCUSSION
Our prospective study suggests a reversible decline in
GFR and albuminuria during LPD for four weeks in
insulin-dependent diabetic patients with diabetic ne-
phropathy. The observed changes in GFR and albumin-
uria were not explained by changes in systemic blood
pressure, which remained essentially unchanged during
LPD. The initial decline in GFR during LPD was greater
in patients with elevated baseline GFR, as also docu-
mented in the Modification of Diet in Renal Disease
study [14].
Initiation of LPD (or pharmacological blood pressure
lowering) in IDDM patients with elevated urinary albu-
min excretion and patients with nondiabetic glomerulo-
pathies induces a faster initial (during the first four
months) and a slower subsequent (four months to end
of study) decline in GFR [8, 16, 22–24]. This short-term
effect of protein restriction offsets the potential long-
term beneficial effect of LPD on the progression of renal
disease, as suggested in the Modification of Diet in Renal
Disease study [8]. However, if the initial decline in GFR
is reversible (hemodynamic) and does not attenuate over
time, then only the sustained decline in GFR, reflecting
progression in renal disease, should be analyzed. In con-
trast, if the initial decline in GFR during LPD reflects
structural damage (irreversible), for example, closure of
moderately/severely ischemic damaged glomeruli, it has
to be accounted for when evaluating the long-term ef-
fects of intervention on progression in kidney disease.
We do not have any information on the physiological
determinants of GFR, that is, the transcapillary hydraulic
pressure difference (DP), the ultrafiltration coefficient
(Kf), and the transcapillary oncotic pressure difference
(Dp) in humans, but both hemodynamic and nonhemo-
dynamic factors seem to be modified by dietary protein
Fig. 1. Correlations between relative change in dietary protein intake
restriction in patients with renal disease [25–27]. Micro-and relative change in albuminuria in 29 insulin-dependent diabetic
patients with diabetic nephropathy. (A) Phase I: At baseline, the pa- puncture studies have indicated that the abnormally ele-
tients were randomized to either LPD (•) or NPD (3) for four weeks vated intraglomerular hydraulic pressure (PGC) and the(r 5 0.51, P , 0.01). (B) Phase II: All patients received NPD from
increased glomerular plasma flow rate [28] seen in exper-week 4 to week 8 (r 5 0.38, P 5 0.05). LPD, low-protein diet (0.6 g ·
kg21 · 24 hr21); NPD, normal-protein diet. imental progressive glomerular diseases are reduced by
dietary protein restriction [6, 29]. It has been suggested
that these hemodynamic effects of LPD may be explained
by alterations in preglomerular and/or postglomerular
vascular resistance and changes in the tubuloglomerular
feedback system [6, 30–32]. Recently, nonhemodynamic
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Previous data suggest that the initial decline in GFR
seen after the initiation of antihypertensive treatment
in hypertensive IDDM patients suffering from diabetic
nephropathy is reversible and does not attenuate over
time [33]. The initial decrease in GFR seems to be ex-
plained by the pharmacologically induced reduction in
systemic arterial blood pressure [33], as autoregulation
of GFR, that is, the maintenance of relative constancy of
GFR despite variations in mean arterial blood pressure,
is abolished or impaired in patients with diabetic ne-
phropathy [34]. Recently, Ruilope, Casal and Praga dem-
onstrated a reversible decline in GFR during two weeks
of LPD in patients with nondiabetic nephropathies [35].
Correspondingly, our short-term study suggests that the
initial decline in GFR, seen after the initiation of LPD in
IDDM patients with diabetic nephropathy, is completely
reversible. Whether this reversibility in GFR is con-
served during long-term treatment with LPD has to be
elucidated. Interestingly, the initial reduction in GFR
demonstrated during LPD was present during antihyper-
tensive treatment (primarily with ACE inhibitors) and
was not explained by changes in systemic blood pressure,
because no effect of LPD on systemic arterial blood
pressure was observed in our IDDM patients with dia-
betic nephropathy. Nevertheless, we found an associa-
tion between DMABP% and DGFR% during phase I in
the NPD group, but not in the LPD group. Because
autoregulation of GFR is impaired/abolished in diabetic
nephropathy [34], even during antihypertensive treat-
ment, it is likely that changes in normal systemic blood
pressure are transmitted, in part, downstream to the glo-
meruli affecting the GFR, as demonstrated in the NPD
group. Because the association between DMABP% and
DGFR% disappeared during LPD (LPD group), our
findings provide some support for the concept that the
reduction in GFR seen during LPD is due to a mecha-
nism different from that induced by antihypertensive
treatment (especially ACE inhibitors) [14, 35], probably
by improving the abolished or impaired autoregulation
of GFR seen in IDDM patients with diabetic nephropa-
thy. This assumption is furthermore supported by previ-
ous findings by Bidani, Schwartz and Lewis, who found
Fig. 2. Correlations between relative change in mean arterial blood that LPD (8%) preserved renal autoregulation and pro-
pressure (MABP) and relative change in glomerular filtration rate tected the remnant kidney against the development of(GFR) in 29 insulin-dependent diabetic patients with diabetic nephropa-
hypertensive injuries [36].thy receiving either (A) LPD (•; r 5 20.06, P 5 0.84) or (B) NPD
(1; r 5 0.71, P , 0.005) during the first four weeks of investigation A few animal studies have suggested a beneficial effect
(phase I). LPD, low-protein diet (0.6 g · kg21 · 24 hr21); NPD, normal- of calorie restriction (40%) [37, 38] on the development
protein diet.
of end-stage renal pathology in the 5/6 nephrectomized
rat. Whether the significant, but small (9%), decrease in
energy intake during phase I in the LPD group contrib-effects, such as reduced uptake of plasma proteins in the
utes to the decline in GFR during this phase is unknown,mesangium and decreased renal expression of trans-
but seems, in this study, to be small or negligible, as GFRforming growth factor and other growth factors [7], have
rose significantly during phase II, despite an unchangedbeen suggested to contribute to the diminished develop-
energy intake. It appears in this study that the observedment and progression of glomerular sclerosis in experi-
mental renal diseases during LPD [27]. decline in calorie (energy) intake during LPD was due
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cardiovascular mortality in insulin dependent diabetes mellitus.to a failed increase in daily intake of carbohydrates and
BMJ 294:1651–1654, 1987
fat, despite a recommended isocaloric diet. 5. Krolewski M, Eggers PW, Warram JH: Magnitude of end-stage
renal disease in IDDM: A 35 year follow-up study. Kidney IntBecause improved glycemic control does not have any
50:2041–2046, 1996short- or long-term effects on albuminuria or GFR in
6. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA,
diabetic nephropathy [39, 40], it is unlikely that the slight Brenner BM: Hyperfiltration in remnant nephrons: A potentially
adverse response to renal ablation. Am J Physiol 241:F85–F93,but significant reduction in hemoglobin A1c seen during
1981protein restriction should affect the renal outcome in
7. Hostetter TH, Meyer TW, Rennke HG, Brenner BM: Chronic
this study. effects of dietary protein in the rat with intact and reduced renal
mass. Kidney Int 30:509–517, 1986We have confirmed and extended the previously re-
8. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusekported [9] reversible decrease in albuminuria during
JW, Striker G, Modification of Diet in Renal Disease Study
LPD in IDDM patients with diabetic nephropathy. Fur- Group: The effects of dietary protein restriction and blood-pres-
sure control on the progression of chronic renal disease. N Englthermore, we have demonstrated that this antiprotein-
J Med 330:877–884, 1994uric effect of LPD is present during antihypertensive
9. Ciavarella A, Di Mizio G, Stefani S, Borgnina LC, Vannini P:
treatment. Studies in IDDM patients with diabetic ne- Reduced albuminuria after dietary protein restriction in insulin-
dependent diabetic patients with clinical nephropathy. Diabetesphropathy have suggested that albuminuria is pressure
Care 10:407–413, 1987dependent to a large extent [34], but other studies in
10. Zeller KR, Whittaker E, Sullivan L, Raskin P, Jacobson HR:
animals and humans with nondiabetic glomerulopathies Effect of restricting dietary protein on the progression of renal
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